ProCE Banner Activity

Recent Updates in the Management of Relapsed/Refractory Follicular Lymphoma

Slideset Download

Download this slideset from a live CCO webinar for an expert overview of recent updates in R/R FL with a focus on second-line therapies and third-line epigenetic modifiers and PI3K inhibitors, including data from ASH 2022.

Released: February 02, 2023

Expiration: February 01, 2024

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Genentech, a member of the Roche Group

MEI Pharma Inc